Activity of the investigational fluoroquinolone finafloxacin and seven other antimicrobial agents against 114 obligately anaerobic bacteria. 2014

G H Genzel, and W Stubbings, and C S Stîngu, and H Labischinski, and R Schaumann
Institute for Medical Microbiology and Epidemiology of Infectious Diseases, University of Leipzig, Leipzig, Germany. Electronic address: gelimergenzel@bundeswehr.org.

The activity of finafloxacin against 73 strains of the Bacteroides fragilis group, 10 other Gram-negative anaerobic rods and 31 Clostridium difficile strains was determined by the broth microdilution technique. The activity was compared with that of moxifloxacin, levofloxacin, ciprofloxacin, clindamycin, imipenem, piperacillin/tazobactam and metronidazole. MIC(50/90) values (minimum inhibitory concentration, in μg/mL, at which 50% and 90% of the isolates tested are inhibited, respectively) for finafloxacin for the different species were determined: B. fragilis group, 0.5/2; other Gram-negative rods, 0.06/0.25; and C. difficile, 4/16. Furthermore, the MICs against 11 selected B. fragilis strains were determined under acidic conditions and resulted in MIC(50/90) values for finafloxacin of 0.25/4 μg/mL. Thus, finafloxacin shows promising activity against several pathogenic species of anaerobes. Furthermore, finafloxacin has increased activity against selected B. fragilis strains under acidic conditions compared with activity at neutral pH.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D001421 Bacteria, Anaerobic Bacteria that can survive and grow in the complete, or nearly complete absence of oxygen. Anaerobic Bacteria
D024841 Fluoroquinolones A group of QUINOLONES with at least one fluorine atom and a piperazinyl group. Fluoroquinolone

Related Publications

G H Genzel, and W Stubbings, and C S Stîngu, and H Labischinski, and R Schaumann
July 2000, The Journal of antimicrobial chemotherapy,
G H Genzel, and W Stubbings, and C S Stîngu, and H Labischinski, and R Schaumann
November 2000, International journal of antimicrobial agents,
G H Genzel, and W Stubbings, and C S Stîngu, and H Labischinski, and R Schaumann
April 2010, Antimicrobial agents and chemotherapy,
G H Genzel, and W Stubbings, and C S Stîngu, and H Labischinski, and R Schaumann
December 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
G H Genzel, and W Stubbings, and C S Stîngu, and H Labischinski, and R Schaumann
May 1979, Chest,
G H Genzel, and W Stubbings, and C S Stîngu, and H Labischinski, and R Schaumann
July 1978, The Journal of antimicrobial chemotherapy,
G H Genzel, and W Stubbings, and C S Stîngu, and H Labischinski, and R Schaumann
June 1985, The Journal of antimicrobial chemotherapy,
G H Genzel, and W Stubbings, and C S Stîngu, and H Labischinski, and R Schaumann
June 1995, Journal of chemotherapy (Florence, Italy),
G H Genzel, and W Stubbings, and C S Stîngu, and H Labischinski, and R Schaumann
April 1988, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!